Association Between Intensive Care Unit Usage and Long-Term Medication Adherence, Mortality, and Readmission Among

Alexander C Fanaroff1, Anita Y Chen2, Sean van Diepen3

  • 1Cardiovascular Outcomes, Quality and Evaluative Research Center, Leonard Davis Institute of Health Economics, and Cardiovascular Medicine Division University of Pennsylvania Philadelphia PA.

Insights

Routine intensive care unit (ICU) use for stable non-ST-segment-elevation myocardial infarction (NSTEMI) patients offers no long-term outcome benefits. High ICU use showed no difference in medication adherence, mortality, or readmission compared to low ICU use hospitals.

Area of Science:

  • Cardiology
  • Healthcare Management
  • Outcomes Research

Background:

  • Hospital practices vary in intensive care unit (ICU) utilization for hemodynamically stable non-ST-segment-elevation myocardial infarction (NSTEMI) patients in the U.S.
  • The impact of ICU use on long-term outcomes following NSTEMI remains unclear.

Purpose of the Study:

  • To investigate the association between hospital-level intensive care unit (ICU) utilization and 1-year outcomes in patients with non-ST-segment-elevation myocardial infarction (NSTEMI).

Main Methods:

  • Analysis of 65,256 patients aged ≥65 with NSTEMI (excluding cardiogenic shock/cardiac arrest) using National Cardiovascular Data Registry and Medicare claims (2011-2014).
  • Hospitals were categorized by ICU usage rates: high (>70%), intermediate (30%-70%), and low (<30%).
  • Multivariable regression models compared 1-year medication non-adherence, cardiovascular readmission, and mortality across hospital types.

Main Results:

  • High ICU usage hospitals showed no significant differences in medication non-adherence, mortality, or cardiovascular readmission compared to low ICU usage hospitals.
  • Intermediate ICU usage hospitals were associated with lower rates of evidence-based therapy and diagnostic catheterization within 24 hours.
  • Patients from intermediate ICU usage hospitals had higher risks of 1-year mortality and medication non-adherence compared to low ICU usage hospitals.

Conclusions:

  • Routine intensive care unit (ICU) admission for hemodynamically stable non-ST-segment-elevation myocardial infarction (NSTEMI) patients is unlikely to improve long-term outcomes.
  • Hospital-level ICU utilization rates did not correlate with significant differences in medication adherence, mortality, or cardiovascular readmission for high-usage facilities.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
174
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions01:24

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
171
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
164
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
123
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
246
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604